Why oil prices are increasing amidst Iran-Israel tensions
The story so far: Escalating tensions between West Asian nations Iran and Israel since last week sent prices of oil spiralling upwards with fears mounting about a potential disruption in oil supplies globally. The benchmark Brent crude futures had soared about 9% Friday (June 13) to $75.65 for a barrel after it hit an intraday high of $78.50/barrel – a near five-month high. The paradigm however sought to ease Monday when news reports suggested that Tehran has asked Qatar, Saudi Arabia and Oman to press U.S. President Donald Trump to help Israel agree for an immediate ceasefire. At the time of writing (about 8 p.m.), Brent crude futures were about 2.4% higher from Monday at $74.98/barrel.
Why is the tension causing oil prices to rise?
At the centre of the entire paradigm is Iran's recurrent threats to close down the Strait of Hormuz. It is the chokepoint that connects the Persian Gulf with the Gulf of Oman and Arabian Sea. For perspective, chokepoints are narrow channels along widely used global sea routes that are utilised for transporting oil through sea. The closure of a chokepoint, even if for a temporary period, can translate to potential delays in supply, reduction in traffic and rise in shipping and insurance costs. All of it culminating into increased price of energy fuel. Though alternatives exist for some chokepoints, but they could entail significant increase in transit times.
In fact, from the larger perspective of trade, Pankaj Chadha, Chairman of the Engineering Exports Promotion Council of India explained The Hindu last week that the escalation of the conflict in the Middle East would bar access to the Suez Canal and the Red Sea. '(This) will have a huge cost and time escalation for Indian exports by ship,' Mr. Chadda held.
U.S.' Energy Information Administration (EIA) in an analysis published Monday held that the Strait was 'deep and wide enough' to handle the world's largest crude oil tankers. It further observed that the Strait facilitated transportation of an average of 20 million barrels each day (md/d) in 2024. This is equivalent to approximately one-fifth of the global petroleum liquids consumption. Additionally, the Paris-based International Energy Association (IEA) attributed the Strait to have served as the exit route from the Gulf for approximately one-fourth of the global oil supply including from major oil-producing nations Saudi Arabia and United Arab Emirates alongside Kuwait, Qatar, Iraq and Iran itself.
According to EIA's estimates, 84% of the crude oil and condensate alongside 83% of liquified natural gas transported via the Strait headed to Asian countries in 2024. Primarily, this includes China, India, Japan and South Korea.
How is the world positioned to manage the uncertainty?
IEA indicated in their June outlook published Tuesday that oil markets in 2025 'look well supplied' in the absence of a major disruption. This is premised around expectations of supply being able to surpass demand. IEA forecasts world oil demand to increase by 720 thousand barrels a day (kb/d) this year whilst supply is projected to rise 1.8 mb/d to 104.9 mb/d. Additionally, it observed from preliminary data that global observed oil inventories have risen by 1 mb/d on an average since February, and 93 million barrels in May alone. However, it cautioned, 'While the market looks comfortably supplied now, the recent events sharply highlight the significant geopolitical risk to oil supply security.'
Furthermore, JM Financial observed in their recent sectoral report that there could be a 'huge upside risk' if Iran disrupts the supply from the Strait of Hormuz. However, it holds the scenario is 'extremely unlikely' as in the past, for 'U.S. and Western countries are likely to take strong measures against any such disruptions given the huge risk it can pose to global oil and gas prices and, hence, inflation.'
Imperative to note though that Iran's own production capacity may not have a significant bearing in the paradigm. This is owing to U.S. sanctions on import of Iranian crude oil. Tehran's major export destination is China. Refineries in the Asian country have particularly benefited from discounted fuel from the West Asian counterpart.
What does it mean back home?
Aditi Nayar, Chief Economist at ratings agency ICRA, observed that while crude oil prices have risen quite sharply over the past few days, it has been from 'rather benign levels'. She holds that should the price persist at the current levels, it may not lead to a 'material revision' in ICRA's GDP forecast of 6.2% for the fiscal. 'However, a sustained increase from the current levels would weigh on India Inc's profitability and the extended uncertainty may further delay private capex expenditure,' Ms. Nayar told The Hindu. She summarised this could potentially translate to a downward revision in ICRA's GDP growth projections for the second half of the fiscal.
Albeit in an unrelated context, Paras Jasrai, Associate Director at India Ratings and Research observed the conflict between Israel and Iran added 'fuel to the global economic uncertainty' marred by tariffs-led volatility. 'The crude oil prices are in the vicinity of $75/barrel. If the conflict escalates further, then that could spring up wholesale inflation and have broader economic ramifications,' he held. Mr. Jasrai adds that favourably though declining food prices have 'given a cushion in keeping wholesale inflation at tepid levels'.
The primary concern with respect to India could potentially be about how things shape up at the Strait of Hormuz. This is because India does not import petroleum crude from Tehran. Amit Kumar, Partner and Energy and Renewable Industry Leader at Grant Thorton Bharat had told The Hindu last week, 'India imports more than 80% of its crude oil needs. Hence, even if direct imports from Iran are minimal, global price spikes due to conflict will raise crude oil import costs.'
On the aspect of supply, imperative to note that Union Petroleum Minister Hardeep Singh Puri in a social media post on Monday has affirmed the India having diversified their import basket substantially are comfortably placed to meet their fuel supply needs.
With inputs from TCA Sharad Raghavan
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


News18
31 minutes ago
- News18
Vedanta, SAIL, Hindalco Drag: What's Behind The Selloff In Metal Stocks Today? Explained
Last Updated: Metal Stocks Today: The sharp fall in the share prices pushed the Nifty Metal index down over 1 per cent to hover around 9,062 Why Are Metal Stocks Falling Today? Metal stocks lagged behind on Thursday, June 19, with the Nifty Metal index falling 1% in an otherwise flat market. This marked the third consecutive day of losses for the index, which has now shed 2.7% after a sharp 7% rally in May. The pullback is being attributed to profit-taking, a firmer US dollar, and rising geopolitical tensions, particularly in the Middle East and over stalled US–China trade talks. Profit-Booking After May Rally After a strong rebound last month, investors booked profits across the metals space. Lingering uncertainty in US–China trade negotiations has weakened sentiment around global commodities, while the surge in energy prices due to Middle East tensions has further spooked investors. Concerns escalated after US President Donald Trump hinted at potential American military action against Iran's nuclear facilities. The geopolitical stress pushed oil prices higher, raising fears over input cost inflation for metal producers, who are highly sensitive to energy price swings. Fed Holds Rates, Warns of Inflation Spike The US Federal Reserve held its benchmark interest rate steady but projected elevated inflation due to President Trump's import tariffs. Fed Chair Jerome Powell noted that tariffs will likely be passed down to end consumers, warning of 'meaningful inflation" in the coming months. Vedanta led the losses within the Nifty Metal index, slipping over 2%, followed by Hindustan Zinc, which declined nearly 1%. Other key laggards included Hind Copper, SAIL, APL Apollo, NALCO, NMDC, and Tata Steel, all down over 0.5%. However, a few stocks bucked the trend. Jindal Stainless, JSW Steel, Jindal Steel, Lloyd Steel & Engineering, and Adani Enterprises posted intraday gains, driven by company-specific tailwinds or stronger earnings. Outlook: Margin Pressures and Dollar Strength in Focus Analysts warn that elevated input costs, narrowing price spreads, and a stronger dollar could continue to pressure margins. While a strong dollar boosts export realizations, it also raises the cost of importing raw materials like coking coal, nickel, and ferroalloys. If the dollar rally persists, especially alongside a slowdown in global growth, metal demand—particularly from China—could take a hit. Indian metal companies, though positioned well domestically, may face global demand headwinds and thinner profit margins in the near term. First Published: June 19, 2025, 11:58 IST

Time of India
35 minutes ago
- Time of India
'A Fine Man': Trump Praises Asim Munir After Pakistan Army Chief Backs US President For Nobel Prize
US President Donald Trump sparked a diplomatic stir by hosting Pakistan Army Chief Asim Munir for lunch at the White House—the first-ever solo visit by a Pakistani General. Trump claimed he 'stopped a war' between India and Pakistan, praising both PM Narendra Modi and Munir for de-escalation. Trump also declared, 'I love Pakistan' and said he had a call with PM Modi to discuss future trade deals. White House has also confirmed that the invite to Pak Army Chief was sent after General Munir backed the US President for the Nobel Peace Prize for reportedly brokering the ceasefire deal between India and Pakistan after Operation Sindoor. India has rejected Trump's narrative. PM Modi reportedly spoke to Trump just before the meeting to reaffirm that the recent ceasefire after the May 7–10 military standoff was entirely brokered through direct communication between the Indian and Pakistani militaries, with no external mediation.#donaldtrump #asimmunir #pakistan #pakistanarmy #trumpasimmunir #pakistanusrelations #whitehouse #nobelpeaceprize #pakarmywhitehouse #trumppakistan #geopolitics #india #terrorism #operationsindoor #toi #toibharat #bharat #breakingnews #indianews Read More
&w=3840&q=100)

Business Standard
38 minutes ago
- Business Standard
Herbal medicine firm Regencell Bioscience skyrockets 60,000%, stuns market
A Hong Kong-based company with no revenue, no regulatory approvals, and fewer than 15 employees has seen its stock surge nearly 60,000 per cent year-to-date on June 16, 2025. Traditional medicine firm Regencell Bioscience Holdings, listed on the US stock exchange, has rallied sharply in recent days, including a nearly fourfold jump in a week, stunning market watchers and prompting questions over the nature of the gains and what might be driving them. Regencell Bioscience was founded in 2014 and incorporated in the Cayman Islands, though its operations are run through two subsidiaries based in Hong Kong. It went public on the Nasdaq in July 2021, raising approximately $21 million through its initial public offering. Screengrab of Regencell Bioscience stock movement Regencell Bioscience company profile: What we know The company develops liquid-based formulas rooted in traditional Chinese medicine (TCM), which it claims can help manage neurological conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). These are proprietary blends made from natural ingredients and are still undergoing internal trials. No regulatory approvals have been secured, and the company has not launched any commercial products. Despite this, the company is now worth more on paper than many established global companies. Regencell reported a combined loss of $10.4 million over the last two financial years and has yet to generate any revenue. The company employs a small team of around 12 people. The company's founder and chief executive officer, Yat-Gai Au, owns approximately 86 per cent of the outstanding shares, effectively controlling the company. Track LIVE Stock Market Updates How a stock split led to a sudden surge The rise in Regencell's share price appears to have been triggered by a 38-for-1 stock split, which came into effect in early June. While such splits do not impact a company's fundamental valuation, they can generate interest by lowering the per-share price. Following the split, Regencell's share price jumped 283 per cent in a single day, briefly pushing its market capitalisation close to $39 billion, higher than companies such as Kraft Heinz and Reddit. The stock rallied despite the absence of new business developments, product announcements, or regulatory progress. Much of the activity appears speculative, with discussion on retail investor forums such as Reddit fuelling interest in Regencell as a so-called 'meme stock'. The situation stands as an example of how low-float stocks can spiral out of control in speculative markets. Why the stock may have risen? Beyond the stock split, several factors may have contributed to Regencell's rise. Only 30 million of the company's 500 million shares are publicly traded. That means even small spikes in demand can move the price dramatically. The tightly held structure, with most shares owned by the founder and a small group of investors, makes the stock susceptible to volatility. There may also be a broader sentiment at play. US interest in natural health may have played a role The surge coincided with renewed debate in the United States around vaccine alternatives and natural health remedies, including comments by public figures questioning conventional immunisation practices. Regencell's positioning as a traditional medicine company, despite making no claims in this space, may have drawn attention from retail traders looking for exposure to alternative healthcare options. What does this soaring valuation mean for Regencell? A market capitalisation of $39 billion for a firm with under 15 employees has raised eyebrows across the financial community. Despite its massive paper valuation, Regencell remains an early-stage company with no commercial revenue and limited operational capacity. Regulatory warnings have already flagged this type of activity. The Financial Industry Regulatory Authority (FINRA) and the US Securities and Exchange Commission have cautioned investors about small-cap foreign stocks with limited free float being vulnerable to manipulation. Alternative medicine market on the rise Globally, interest in traditional and alternative medicine is rising. The complementary and alternative medicine (CAM) market was valued at $178.5 billion in 2024 and is projected to reach $919.5 billion by 2034, growing at a compound annual growth rate of 17.9 per cent, according to Global Market Insights, driven by rising demand for holistic, non-invasive, and natural health solutions. Market research also expects China's TCM industry, valued at $19.5 billion in 2022, to reach nearly $48 billion by 2030. Policy support and public interest in wellness products have driven sustained growth. However, stock surges in the sector have typically followed regulatory decisions or mergers, and have not approached the scale seen in Regencell's case. Ayurveda market grows with demand In India, the Ayurveda and herbal health segment has also expanded rapidly, supported by both government backing and rising consumer demand. The domestic market is projected to grow to ₹36 trillion by 2033 from ₹8.76 trillion in 2024, according to research shared by Imarc Group. Listed companies such as Dabur and Kerala Ayurveda have delivered strong financial performances, driven by product demand and retail penetration. Unlike Regencell, their valuations have been more closely tied to business metrics. As of Wednesday, June 18, the stock had dropped 18 per cent in intraday trading to $63.35 on Nasdaq, but it was still up 48,630.77 per cent year-to-date.